Introduction
============

As a transcription factor, Nrf2 (nuclear factor, erythroid 2 like 2) regulates an inducible defense system against oxidative stress and is a member of a small family of basic leucine zipper (bZIP) proteins. After binding to a short antioxidant response element (ARE) in the promoters, Nrf2 triggers the expression of detoxification genes including those involved in redox homeostasis, glutathione turnover, and iron metabolism ([@B11]). In the central nervous system (CNS), Nrf2 defends against oxidative stress to provide a protective response by being released from Kelch ECH associating protein 1 (Keap1) and translocating to the nucleus, where it binds the ARE and drives gene expression ([@B57]). This protein can prevent oxidant injury in neurons, attenuate NO-dependent neuronal apoptosis, decrease neuronal injury during cerebral ischemia, and ameliorate neurodegeneration in neurodegenerative disease ([@B43], [@B44]; [@B50]).

Many neurodegenerative diseases are associated with the failure of specific populations of neurons, such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis ([@B21]). These neurodegenerative diseases share common pathogenic processes, such as oxidative stress, excitotoxicity and glial activation, in which astrocytes gain a reactive phenotype that can be either protective or detrimental to neurons ([@B45]; [@B22]). Previous studies regarding gain and loss of function of Nrf2 in the brain have suggested that the induction of Nrf2 can ameliorate neurodegeneration, whereas Nrf2 deficiency exacerbates neurodegenerative phenotypes ([@B59]). Additionally, Nrf2 is activated in all these neurodegenerative diseases, and Nrf2 activity varies in the regions associated with Alzheimer's disease, with a tendency for greater Nrf2 activity in the hippocampus and less activity in the frontal cortex ([@B14]; [@B21]). Hence, Nrf2 is believed to play a major role in neurodegenerative diseases.

With advances in sequencing technology, various non-coding RNAs have been shown to have significant functions in regulating gene expression ([@B48]). Circular RNAs (circRNAs), a novel type of endogenous non-coding RNA, are expressed with tissue/developmental stage-specificity and are significantly enriched in the brain ([@B56]). An increasing body of evidence indicates the strong association of circRNAs with the development of several CNS diseases, such as AD, PD, and stroke ([@B10]; [@B27]). Additionally, the specific expression of circRNAs and their stability indicate their potential as molecular diagnostic biomarkers for neurodegenerative diseases, such as CDR1 in AD ([@B25]).

Similarly, as a novel class of RNA transcripts, long non-coding RNAs (lncRNAs) have been demonstrated to be involved in a wide range of epigenetic regulatory mechanisms *via* their direct or indirect interactions with chromatin, and play a critical role in development, differentiation, and homeostasis ([@B53]; [@B39]). Several studies have explored the relationship between lncRNAs and Nrf2-mediated diseases. [@B58] suggested that low lncRNA Hox transcript antisense intergenic RNA (HOTAIR) expression was associated with down-regulation of Nrf2 in the spermatozoa of patients with asthenozoospermia or oligoasthenozoospermia. [@B54] demonstrated that the functional interaction between lncRNA-MEG3 and Nrf2 constitutes the mechanism by which TGF-β2 induces Tenon's capsule fibroblast proliferation after glaucoma filtration surgery *via* the direct binding of MEG3 to Nrf2. Although the role of circRNAs and lncRNAs in the context of various neurodegenerative diseases has been proposed, the precise mechanism is yet to be elucidated.

In our previous study, we detected the altered expression of circRNAs and lncRNAs in the substantia nigra and corpus striatum tissue of Nrf2-null mice ([@B23]; [@B55]), and considering that Nrf2 activity may diverge across different brain regions, the current study focused on the expression profiles of circRNAs and lncRNAs in the hippocampus tissue of Nrf2-null mice. Previous studies showed definitively that the hippocampus and neighboring structures of the medial temporal lobe are essential to memory ([@B37]). The hippocampus plays a critical role in memory formation, which is widely regarded as being central in a brain network that supports encoding and consolidation of memory and, being central to the study of human memory, and has been implicated in episodic and semantic long-term memory ([@B1]; [@B17]). Hence, we further analyzed differentially expressed mRNAs (DEmRNAs), circRNAs (DEcircRNAs) and lncRNAs (DElncRNAs) in the hippocampus between Nrf2 (−/−) and Nrf2 (+/+) mice by microarray analysis. The construction of the DEcircRNA-miRNA-DEmRNA interaction network and DElncRNA-DEmRNA co-expression network was then performed to explore the key circRNAs and lncRNAs correlated with Nrf2-mediated neuroprotection.

Materials and Methods
=====================

Nrf2-Knockout Mice and Ethics
-----------------------------

Three adult male Nrf2 (+/+) mice (25 to 30 g, 3 to 4 months, *n* = 3) and three Nrf2 (−/−) mice (25 to 30 g, 3 to 4 months, *n* = 3), which were kindly provided by academician Chun-Yan Li (Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China), were used for this study. The present study utilized mice with an ICR (Institute of Cancer Research) background. Three mice were randomly selected for each group (*n* \> 20) in a random manner. The mice were housed in a 12 h light/dark cycle in a temperature-controlled environment and fed *ad libitum*, with 4 to 5 mice per cage. None of these mice underwent perfusion. By using polymerase chain reaction (PCR) amplification of genomic DNA from tails, the genotypes \[(Nrf2 (+/+) and Nrf2 (−/−)\] of the mice were determined. The PCR primers used in the identification of genotypes and the electrophoresis image are shown in [Supplementary Figure S1](#FS1){ref-type="supplementary-material"} and [Supplementary Table S1](#TS1){ref-type="supplementary-material"}, respectively. All the mice were sacrificed by using an overdose of an isoflurane/oxygen mixture (Huazhong Haiwei Gene Technology, Co., Ltd., Cat. No. 021400, Beijing, China). Hippocampal tissues of each mouse were obtained from surgery, and immediately homogenized for the extraction of total RNA (TRIzol, Invitrogen, Cat No. 15596026, Carlsbad, CA, United States).

In this study, the animal experiments complied with the regulations of the Animal Welfare Act of the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) and were approved by the ethics committee of Hebei Medical University (IACUC-Hebmu-Glp-2016017). All investigators were blinded. The study was not pre-registered.

CircRNA Microarrays
-------------------

The circRNA microarray was analyzed using Arraystar Mouse circRNA Array V2 analysis (Arraystar, Inc., United States) by Kangchen BioTech, Inc. (Shanghai, China). By using a NanoDrop ND-1000 instrument (Nanodrop Technologies, Inc.), the concentration of total RNA was determined by OD260. The integrity of total RNA was assessed by electrophoresis (Liuyi Instrument Factory, Cat No. DDY-5, Beijing, China) on a denaturing agarose gel (Gene Company, Ltd., Cat No. EEO015, China).

LncRNA and mRNA Microarrays
---------------------------

Arraystar Mouse LncRNA Microarray V3.0 (Rockville, MA, United States) is designed for the global profiling of mouse lncRNAs and protein-coding transcripts. The lncRNAs were carefully constructed using the most reputed public transcription databases (Refseq, UCSC known genes, Ensembl, etc.), as well as landmark publications. Each transcript is represented by a specific exon or splice junction probe, which can accurately identify the individual transcripts. Positive probes for housekeeping genes and negative probes were also printed onto the array for hybridization quality control.

RNA Labeling and Array Hybridization
------------------------------------

Based on the manufacturer's protocol, sample-circRNA labeling and array hybridization were performed. Briefly, to remove linear RNAs and enrich circular RNAs, total RNA was digested with RNase R (Epicentre, Inc., Cat No. RNR07250, United States) and the enriched circular RNAs were amplified and transcribed into fluorescent cRNA by utilizing a random priming method with an Arraystar Super RNA Labeling Kit (Arraystar, Inc., Cat No. AS-LE-005, United States). With a RNeasy Mini Kit (Qiagen, Cat No. 74104, Germany), the fluorophore-labeled cRNA was purified. By using a NanoDrop ND-1000 (Nanodrop Technologies, Inc.), the concentration and specific activity of labeled cRNAs (pmol Cy3/μg cRNA) were measured. One microgram of each labeled cRNA was fragmented by adding 5 μl 10× Blocking Agent and 1 μl of 25× Fragmentation Buffer, and then, the mixture was heated at 60°C for 30 min. Finally, 25 μl 2× hybridization buffer (Agilent, Cat No. 5190-0403, United States) was added to dilute the labeled cRNA. Hybridization solution (50 μl) was dispensed into the gasket slide (Agilent, Cat No. G2534-60003, United States) and assembled to a mouse circRNA microarray (8 × 15K, Arraystar) slide. In an Agilent hybridization oven (Agilent, Cat No. G2545A, United States), the slides were incubated for 17 h at 65°C. The hybridized arrays were washed, fixed and scanned using the Agilent Scanner G2505C (Agilent, Cat No. G2565BA, United States) and scanned images were imported into Agilent Feature Extraction software for raw data extraction. Quantile normalization and subsequent data processing were performed by using the Kangchen homemade R software package (Kangchen BioTech, Inc., Shanghai, China), and then, low intensity filtering was performed.

With minor modifications of the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology, Palo Alto, CA, United States), sample-lncRNA labeling and array hybridization were performed. Briefly, after removal of rRNA, mRNA was purified from total RNA (mRNA-ONLY^TM^ Eukaryotic mRNA Isolation Kit, Epicentre, Madison, WI, United States). Then, along the entire length of the transcripts without a 3′ bias utilizing a random priming method, each sample was amplified and transcribed into fluorescent cRNA (Arraystar Flash RNA Labeling Kit, Arraystar, Rockville, MA, United States). By using a RNeasy Mini Kit (Qiagen, Valencia, CA, United States), the labeled cRNAs were purified. The concentration and specific activity of the labeled cRNAs (pmol Cy3/μg cRNA) were measured by NanoDrop ND-1000 (NanoDrop Technologies, Thermo Scientific, Wilmington, DE, United States). By adding 5 μl 10× Blocking Agent and 1 μl of 25× fragmentation buffer, 1 μg of each labeled cRNA was fragmented, and the mixture was heated at 60°C for 30 min. Finally, 25 μl 2× GE Hybridization buffer was added to dilute the labeled cRNA. Hybridization solution (50 μl) was dispensed into the gasket slide (Agilent, Cat No. G2534-60003, United States) and assembled to the lncRNA expression microarray slide. The slides were incubated for 17 h at 65°C in an Agilent Hybridization Oven (Agilent, Cat No. G2545A, United States). The hybridized arrays were washed, fixed and scanned with the Agilent DNA Microarray Scanner (part number G2505C).

Data Pre-processing
-------------------

To analyze the acquired array images, Agilent Feature Extraction software (version 11.0.1.1) was used. Quantile normalization and subsequent data processing were performed using the GeneSpring GX v12.1 software package (Agilent Technologies). After quantile normalization of the raw data, lncRNAs and mRNAs with flags of at least three out of six samples were chosen for further data analysis. Through *p*-value filtering, lncRNAs and mRNAs with statistical significance between the two groups were identified. DElncRNAs and DEmRNAs between the two samples were identified through fold change filtering. By using homemade scripts, hierarchical clustering, and combined analysis were performed.

DEmRNA, DEcircRNA, and DElncRNA Analyses
----------------------------------------

The expression profiles of mRNAs, circRNAs, and lncRNAs in the hippocampal tissues of Nrf2 (+/+) and Nrf2 (−/−) mice were obtained. The calculation of fold change (FC) and *p*-value between these groups for each mRNA, circRNA, and lncRNA was performed to compare the profile differences in the hippocampal tissues between Nrf2 (+/+) and Nrf2 (−/−) mice. By using a *t*-test, the statistical significance of the difference was estimated. While mRNAs and circRNAs with FC \> 1.5 and *p*-values \< 0.05 were selected as the significantly DEcircRNAs and DEmRNAs, lncRNAs with *p* \< 0.05 and FC \> 2 were identified as DElncRNAs. By using the 'pheatmap' package in R language, hierarchical cluster analysis of group samples based on expression values of mRNAs, circRNAs, and lncRNAs was conducted.

Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) Validation
---------------------------------------------------------------------

According to the manual instructions, total RNA of the hippocampal tissues generated from Nrf2 (−/−) mice and Nrf2 (+/+) mice was extracted using TRIzol (Thermo Fisher Scientific, Wilmington, DE, United States). By using an M-MLV First Strand Kit (Thermo Fisher Scientific, Inc., Cat No. 00341186, United States), total RNA (2 μg) was transcribed to cDNA. By using SuperReal PreMix Plus (SYBR Green) (TIANGEN, Cat No. FP205, China) with an Illumina Eco PCR machine (Illumina, San Diego, CA, United States), qRT-PCR was performed. QRT-PCR reaction conditions were as follows: an initial denaturation step of 15 min at 95°C, followed by 40 cycles of 15 s at 95°C and 20 s at 55°C, 20 s at 72°C. For normalization, β-actin was selected as the housekeeping gene. All experiments were performed in triplicate. The 2^--Δ^ ^Δ^ ^*CT*^ method was used to calculate relative fold changes for quantitative results. The PCR primers are displayed in [Table 1](#T1){ref-type="table"}.

###### 

The primers used in qRT-PCR experiments.

  **circRNA**          **Primers**
  -------------------- ---------------------------------------------
  mmu_circRNA_44531    Forward: 5′ TGAATGGCTCTCACCCTGTCTCCTT 3′
                       Reverse: 5′ GCAGTGGCGGACACAGATCTTTAAG 3′
  mmu_circRNA_34132    Forward: 5′ TGAAGAACTCTGTCTACCGAAGCC 3′
                       Reverse: 5′ TAGTCAAAGCCTTGCACGGGAT 3′
  mmu_circRNA_000903   Forward: 5′ ACATGCTCCAGGCCCCTCTGTTTAC 3′
                       Reverse: 5′ GATGAGTGCTTTGCGGAATTTGGTG 3′
  mmu_circRNA_018676   Forward: 5′ ACACCCTTTATGATGTCACACCTTT 3′
                       Reverse: 5′ TCCAAAAGAATAGGCTGGCTGAG 3′
  mmu_circRNA_45901    Forward: 5′ TCAGGCTCGGCTACAGAAGGAAC 3′
                       Reverse: 5' ATAAGATATTGCCACGGTGGATGAA 3′
  mmu_circRNA_33836    Forward: 5′ GAACCTTACTCAAAAGCATCCCACT 3′
                       Reverse: 5' TTGGGCCAACATGTATTATTCTTCC 3′
  mmu_circRNA_34137    Forward: 5′ TCAGCACCAGGAGCAACCTAACAG 3′
                       Reverse: 5′ TCTTGAATCTGTCTGCTGCTGAGGA 3′
  mmu_circRNA_34106    Forward: 5′ GGCTGCTGAAGAGTGAACTTGGAT 3′
                       Reverse: 5′ AGGTGAGGATGGAGCTGTGTCTTC 3′
  mmu_circRNA_008691   Forward: 5′ACACTCATTATTGGCTGGGGAACTT 3′
                       Reverse: 5′ CACACTCCTTATGTTTCCTTCCCCT 3′
  mmu_circRNA_003237   Forward: 5′ AGACGTGGAACCTGCTCAATC 3′
                       Reverse: 5′ GACCTTCCCCAAAACAGACTTC 3′
  **lncRNA**           **Primers**
  uc008nfy.1           Forward: 5′ ATGTCAGGCAGCAGGGACC 3′
                       Reverse: 5′ TCCTTGCTTCCTCTTTGGGTT 3′
  ENSMUST00000125413   Forward: 5′ TCCCTGAGTGTTTATATTTACAGATGGC 3′
                       Reverse: 5′ GCCACACAGTAGGAAGATGAGACCA 3′
  NR_028123            Forward: 5′ GCTCTTCCCCAGTTTCAAGTTCTCA 3′
                       Reverse: 5′ CATTCCAGTCCTCAGATACGCTCAG 3′
  AK076764             Forward: 5′ TATGGACGATATTGTGATTTGTGGACC 3′
                       Reverse: 5′ AGTGGCTCCTAAAAAATGACTAACGTC 3′
  AK142725             Forward: 5′ AAGGAGTGAAGCCACAGCA 3′
                       Reverse: 5′ CCTCAGACACAAGAGAAACCAG 3′
  AK080547             Forward: 5′ TGAGTGTTGTGAGTCTAGGTGAGCT 3′
                       Reverse: 5′ TCCTTGCCAGAGTCTAATGATACCT 3′
  AK035903             Forward: 5′ ACGGCACCTTTATCCAGCCATCT 3′
                       Reverse: 5′ TCTGGAGGGTCTGAAGACAGCTACA 3′
  b-Actin              Forward: 5′ TCATCACTATTGGCAACGAGCGGT 3′
                       Reverse: 5′ GTGTTGGCATAGAGGTCTTTACG 3′

qRT-PCR, quantitative real-time polymerase chain reaction; circRNA, circular RNA; lncRNA, long non-coding RNA.

Functional Annotation of DEmRNAs
--------------------------------

Gene Ontology (GO) classification and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were conducted using the clusterProfiler of R/Bioconductor^[1](#footnote1){ref-type="fn"}^. According to the size of the enrichment factor, we extracted the top 30 terms/pathways.

Construction of DEcircRNA-miRNA-DEmRNA Interaction Networks
-----------------------------------------------------------

The DEcircRNA-miRNA-mRNA interactions were predicted with Arraystar's homemade miRNA target prediction software based on TargetScan & MiRanda ([@B9]; [@B31]). The miRNA--mRNA interactions with total context + + ≤ −0.2 were selected for further analysis. In these DEcircRNA-miRNA-mRNA interaction networks, the circRNAs and mRNAs were linked by shared miRNAs predicted as downstream targets of circRNAs and upstream regulators of mRNAs. Thus, the change in circRNA and mRNA should be in the same direction, and then, we selected DEmRNAs that were indirectly positively regulated by DEcircRNAs for the following research. The DEcircRNA-miRNA-DEmRNA interaction networks were visualized using Cytoscape (version 3.7.0)^[2](#footnote2){ref-type="fn"}^. GO classification and KEGG pathway enrichment were conducted for the target DEmRNAs of miRNAs sponged by DEcircRNAs in the hippocampal tissues using the clusterProfiler of R/Bioconductor^1^. According to the size of the enrichment factor, we extracted the top 10 terms/pathways.

Construction of DElncRNA-DEmRNA Co-expression Networks
------------------------------------------------------

According to their expression levels, the Pearson correlation coefficient (PCC) was used to depict the co-expression relationship between DElncRNAs and DEmRNAs. DElncRNA-DEmRNA pairs with \| PCC\| \> 0.90 and *p* \< 0.05 were retained for network construction, which was deciphered by Cytoscape 3.1^2^. GO classification and KEGG pathway enrichment for DEmRNAs co-expression with DElncRNAs were conducted using the clusterProfiler of R/Bioconductor^1^. According to the size of the enrichment factor, we extracted the top 10 terms/pathways.

Statistical Analysis
--------------------

The investigators were blinded to animal groups to reduce experimenter bias and to achieve unbiased results. No sample size calculation was performed. There were no sample size differences between the beginning and end of the experiments. And qRT-PCR was performed in triplicate. Functional annotation was conducted using the clusterProfiler of R/Bioconductor^1^. Mean ± standard deviation and independent-samples *t*-tests were used in the statistical analysis based on Agilent Genespring GX Linux software (Version 11.5) and IBM SPSS Statistics software (Version 22.0), respectively. Outliers were deleted. A value of *p* \< 0.05 was considered the criterion of statistical significance.

Results
=======

DEmRNAs Between the Nrf2 (−/−) Mice and Nrf2 (+/+) Mice
-------------------------------------------------------

Compared with Nrf2 (+/+) mice, a total of 412 DEmRNAs, including 109 up-regulated and 303 down-regulated mRNAs, were detected in the hippocampus with a \>1.5-fold change and *p*-value \< 0.05 ([Figure 1](#F1){ref-type="fig"} and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Functional annotation of DEmRNAs in the hippocampal tissues was conducted. GO enrichment analysis ([Figure 2A](#F2){ref-type="fig"}) indicated that, the DEmRNAs were enriched in response to cocaine (biological process: 0042220, *p* = 9.471e-04), synapsis (biological process: 0007129, *p* = 3.246e-04), demethylase activity (molecular function: 0032451, *p* = 1.224e-03), synaptonemal complex (cellular component: 0000795, *p* = 1.952e-03), and release of cytochrome c from mitochondria (biological process: 0001836, *p* = 2.416e-03). KEGG pathway enrichment analysis for significantly dysregulated mRNAs was useful to reveal related pathways and molecular interactions. According to the KEGG enrichment analysis ([Figure 2B](#F2){ref-type="fig"}), these DEmRNAs were enriched in the pathways of the calcium signaling pathway (KEGG: mmu04020, *p* = 5.901e-03), long-term depression (LTD) (KEGG: mmu04730, *p* = 5.908e-02), and Parkinson's disease (KEGG: mmu05012, *p* = 7.166e-02), which were closely correlated with neurodegenerative diseases.

![Hierarchical clustering analysis based on the expression profile of the DEmRNAs in the Nrf2 (--/--) hippocampus. *n* = 3.](fnmol-12-00196-g001){#F1}

![The top 30 most significantly enriched GO **(A)** and KEGG **(B)** pathways of DEmRNAs between the Nrf2 (--/--) and Nrf2 (+/+) hippocampus. The x-axis shows counts of genes enriched in GO and KEGG pathways, and the y-axis shows the GO and KEGG pathways. The color scale depicts the *p*-value.](fnmol-12-00196-g002){#F2}

DEcircRNAs and DElncRNAs in the Hippocampus Between the Nrf2 (−/−) Mice and Nrf2 (+/+) Mice
-------------------------------------------------------------------------------------------

Compared to Nrf2 (+/+) mice, a total of 1279 DEcircRNAs, including 632 up-regulated circRNAs and 647 down-regulated circRNAs, were detected in the hippocampus between Nrf2 (−/−) and Nrf2 (+/+) mice with a \>1.5-fold change and *p*-value \< 0.05 ([Supplementary Tables S3](#TS3){ref-type="supplementary-material"}, [S4](#TS4){ref-type="supplementary-material"}). Among them, mmu_circRNA_40139 and mmu_circRNA_26611 were the most up-regulated and down-regulated DEcircRNAs in the hippocampus, respectively ([Table 2](#T2){ref-type="table"}). A total of 303 DElncRNAs, including 50 up-regulated and 253 down-regulated lncRNAs, were identified in the hippocampus of Nrf2 (−/−) mice with a \>2-fold change and *p*-value \< 0.05. ENSMUST00000161755 and ENSMUST00000105610 were the most up-regulated and down-regulated DElncRNAs in the hippocampus, respectively ([Table 3](#T3){ref-type="table"}). Hierarchical clustering of these DEcircRNAs and DElncRNAs indicated an obvious discrimination between Nrf2 (−/−) and Nrf2 (+/+) mice ([Figure 3](#F3){ref-type="fig"}). The raw-data have been uploaded to Gene Expression Omnibus (GEO) (GSE122421, <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122421>; GSE122422, <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122422>).

###### 

Top 10 up- and down-regulated DEcircRNAs in the hippocampus of Nrf2 (−/−) mice.

  **circRNA**         **circRNA\_ type**   **chrom**   ***p*-value**   **Regulation**
  ------------------- -------------------- ----------- --------------- ----------------
  mmu_circRNA_40139   Exonic               chr6        0.00005436006   Up
  mmu_circRNA_44715   Exonic               chr9        0.000203188     Up
  mmu_circRNA_27509   Exonic               chr14       0.000218135     Up
  mmu_circRNA_34109   Sense overlapping    chr2        0.000227424     Up
  mmu_circRNA_28600   Exonic               chr15       0.000264287     Up
  mmu_circRNA_33745   Sense overlapping    chr2        0.000283733     Up
  mmu_circRNA_26322   Exonic               chr13       0.000325369     Up
  mmu_circRNA_29992   Exonic               chr16       0.000380296     Up
  mmu_circRNA_34863   Exonic               chr2        0.000393293     Up
  mmu_circRNA_33826   Exonic               chr2        0.000403672     Up
  mmu_circRNA_26611   Sense overlapping    chr13       0.000155304     Down
  mmu_circRNA_34832   Exonic               chr2        0.000165934     Down
  mmu_circRNA_35957   Exonic               chr3        0.000227463     Down
  mmu_circRNA_34137   Exonic               chr2        0.000492821     Down
  mmu_circRNA_44589   Exonic               chr9        0.000527078     Down
  mmu_circRNA_43020   Exonic               chr8        0.000534644     Down
  mmu_circRNA_34314   Exonic               chr2        0.000545661     Down
  mmu_circRNA_33836   Exonic               chr2        0.000564463     Down
  mmu_circRNA_30123   Exonic               chr16       0.000678283     Down
  mmu_circRNA_33850   Exonic               chr2        0.00071285      Down

DEcircRNAs, differentially expressed circRNAs.

###### 

Top 10 up- and down-regulated DElncRNAs in the hippocampus of Nrf2 (−/−) mice.

  **Seqname**          **Gene symbol**   ***p*-value**   **FDR**       **Fold change**   **Regulation**
  -------------------- ----------------- --------------- ------------- ----------------- ----------------
  ENSMUST00000161755   Setd7             1.04874E-05     0.090718311   19.0132304        Up
  uc012cpj.1           5031434O11Rik     7.82829E-05     0.155417706   8.3313618         Up
  AK037363             AK037363          0.000152779     0.204707508   3.5895181         Up
  uc008nfy.1           AK006531          0.000668524     0.379212113   2.2272505         Up
  AK139259             AK139259          0.000874653     0.432610759   2.789535          Up
  AK139259             AK139259          0.000874653     0.432610759   2.789535          Up
  ENSMUST00000170420   Dusp12            0.001161771     0.436947138   3.0719131         Up
  ENSMUST00000137756   Gm13371           0.001280493     0.436947138   2.4390113         Up
  ENSMUST00000143128   Chia              0.001577294     0.436947138   4.6602429         Up
  ENSMUST00000139157   Tmeff2            0.001698904     0.437780578   3.5387142         Up
  ENSMUST00000105610   Gm17106           1.83126E-05     0.090718311   50.0259527        Down
  TCONS_00018071       XLOC_014960       1.84989E-05     0.090718311   12.0584926        Down
  NR_028263            B130006D01Rik     3.07853E-05     0.091678721   6.5836299         Down
  ENSMUST00000123574   Gm14002           0.000101993     0.186914246   6.3845782         Down
  ENSMUST00000123574   Gm14002           0.000101993     0.186914246   6.3845782         Down
  ENSMUST00000126340   Dcdc5             0.000162376     0.204707508   14.695374         Down
  AK144955             AK144955          0.000197566     0.22130871    7.9976315         Down
  NR_003293            D030028A08Rik     0.000200719     0.22130871    10.7616687        Down
  NR_003293            D030028A08Rik     0.000200719     0.22130871    10.7616687        Down
  AK076764             AK076764          0.000204365     0.22130871    2.1472701         Down

DElncRNAs, differentially expressed lncRNAs; FDR, false discovery rate.

![Hierarchical clustering analysis based on the expression profile of the DEcircRNAs **(A)** and DElncRNAs **(B)** in Nrf2 (--/--) the hippocampus. *n* = 3.](fnmol-12-00196-g003){#F3}

QRT-PCR Validation of the Expression of the Selected DEcircRNAs and DElncRNAs
-----------------------------------------------------------------------------

Ten dysregulated circRNAs, including five up-regulated (mmu_circRNA_44531, mmu_circRNA_34132, mmu_circRNA_000903, mmu_circRNA_018676, and mmu \_circRNA_45901) and five down-regulated DEcircRNAs (mmu_circRNA_33836, mmu_circRNA_34137, mmu_circRNA\_ 34106, mmu_circRNA_008691, and mmu_circRNA_003237), and seven dysregulated lncRNAs, including three up-regulated (ENSMUST00000125413, NR_028123, and uc008nfy.1) and four down-regulated DElncRNAs (AK076764, AK142725, AK080547, and AK035903), with relatively high fold changes, high expression and low *p*-values, were selected for qRT-PCR validation. Compared to Nrf2 (+/+) mice, the 10 dysregulated circRNAs and seven dysregulated lncRNAs were successfully verified by qRT-PCR. Generally, the expression patterns of these selected circRNAs and lncRNAs in qRT-PCR validation results were consistent with those in our microarray results ([Figure 4](#F4){ref-type="fig"}).

![QRT-PCR validation of the expression levels of candidate circRNAs **(A)** and lncRNAs **(B)**. ^\*^*p* \< 0.05 and ^∗∗^*p* \< 0.01. The deep red column indicates the expression status of lncRNAs through microarray analyses; the blue column indicates the expression status of lncRNAs through qRT-PCR experiments. *n* = 3.](fnmol-12-00196-g004){#F4}

DEcircRNA-miRNA-DEmRNA Interaction Networks
-------------------------------------------

In the DEcircRNA-miRNA-DEmRNA interaction networks, mmu_circRNA_44531, mmu_circRNA_34132, mmu_circRNA\_ 000903, mmu_circRNA_018676, mmu_circRNA_45901, mmu\_ circRNA_33836, mmu_circRNA_34137, mmu_circRNA_34106, mmu_circRNA_008691, and mmu_circRNA_003237 were predicted to compete with 47, 54, 45, 57, 63, 81, 121, 85, 181, and 43 DEmRNAs, respectively. The DEcircRNA-miRNA-DEmRNA interaction networks are shown in [Figure 5](#F5){ref-type="fig"}. In the GO enrichment analysis ([Figure 6A](#F6){ref-type="fig"}), DEmRNAs that shared the same binding miRNAs with DEcircRNAs were enriched in chromosome organization involved in meiosis (biological process: 0070192, *p* = 0.00000278), condensed chromosome (cellular component: 0000793, *p* = 0.00001108), negative regulation of extrinsic apoptotic signaling pathway (biological process: 2001237, *p* = 0.00012), response to cocaine (biological process: 0042220, *p* = 0.0002086), demethylase activity (molecular function: 0032451, *p* = 0.0002718), negative regulation of muscle cell apoptotic process (biological process: 0010656, *p* = 0.0005509), and telomere maintenance (biological process: 0000723, *p* = 0.001168). According to the KEGG enrichment analysis ([Figure 6B](#F6){ref-type="fig"}), these DEmRNAs were enriched in the pathways of ECM-receptor interaction (KEGG: mmu04512, *p* = 0.0006341), focal adhesion (KEGG: mmu04510, *p* = 0.000646), LTD (KEGG: mmu04730, *p* = 0.01344), calcium signaling pathway (KEGG: mmu04020, *p* = 0.02193), and type I diabetes mellitus (KEGG: mmu04940, *p* = 0.05376). Three DEmRNAs (IGF1, RYR1, and PLA2G12A) were enriched in LTD. Among them, IGF1 and RYR1 were targets of mmu_circRNA_34106 and mmu_circRNA_008691; RYR1 was the target of mmu_circRNA_34137; and PLA2G12A was the target of mmu_circRNA_33836.

![DEcircRNA-miRNA-DEceRNA interaction subnetworks of up-regulated circRNAs and down-regulated circRNAs in the Nrf2 (--/--) hippocampus. **(A)** Subnetwork of mmu_circRNA_44531 in the Nrf2 (--/--) hippocampus. **(B)** Subnetwork of mmu_circRNA_34132 in the Nrf2 (--/--) hippocampus. **(C)** Subnetwork of mmu_circRNA_000903 in the Nrf2 (--/--) hippocampus. **(D)** Subnetwork of mmu_circRNA_018676 in the Nrf2 (--/--) hippocampus. **(E)** Subnetwork of mmu_circRNA_45901 in the Nrf2 (--/--) hippocampus. **(F)** Subnetwork of mmu_circRNA_33836 in the Nrf2 (--/--) hippocampus. **(G)** Subnetwork of mmu_circRNA_34137 in the Nrf2 (--/--) hippocampus. **(H)** Subnetwork of mmu_circRNA_34106 in the Nrf2 (--/--) hippocampus. **(I)** Subnetwork of mmu_circRNA_008691 in the Nrf2 (--/--) hippocampus. **(J)** Subnetwork of mmu_circRNA_003237 in the Nrf2 (--/--) hippocampus. Yellow nodes indicate DEcircRNAs. Magenta and green nodes indicate miRNAs sponged by DEcircRNAs and the gene ID of their DEceRNAs, respectively. Edges represent interactions.](fnmol-12-00196-g005){#F5}

![The top 30 most significantly enriched GO **(A)** and KEGG **(B)** pathways of DEceRNAs of miRNAs sponged by DEcircRNAs between the Nrf2 (--/--) and Nrf2 (+/+) hippocampus. The x-axis shows counts of genes enriched in GO **(A)** and KEGG **(B)** pathways and the y-axis shows the GO and KEGG pathways. The color scale depicts the *p*-value.](fnmol-12-00196-g006){#F6}

DElncRNA-DEmRNA Co-expression Networks
--------------------------------------

The DElncRNA-DEmRNA co-expression networks, which included the previously mentioned DEmRNAs co-expressed with seven DElncRNAs, were constructed based on expression profiling. ENSMUST00000125413, NR_028123 and uc008nfy.1, which were up-regulated DElncRNAs in Nrf2 (−/−) hippocampal tissues, co-expressed with 178, 89, and 149 DEmRNAs ([Figures 7A--C](#F7){ref-type="fig"}). AK076764, AK142725, AK080547 and AK035903, which were down-regulated DElncRNAs in Nrf2 (−/−) hippocampal tissues, co-expressed with 179, 142, 55, and 112 DEmRNAs ([Figures 7D--G](#F7){ref-type="fig"}). GO enrichment analysis indicated that, the DEmRNAs co-expressed with DElncRNAs were enriched in the release of sequestered calcium ion into cytosol (biological process: 0051209), regulation of sequestering of calcium ion (biological process: 0051282), and release of cytochrome c from mitochondria (biological process: 0001836). According to the KEGG enrichment analysis, these DEmRNAs co-expressed with DElncRNAs were enriched in the pathways of calcium signaling pathway (KEGG: mmu04020), LTD (KEGG: mmu04730), and Parkinson's disease (KEGG: mmu05012) ([Supplementary Table S5](#TS5){ref-type="supplementary-material"}).

![Co-expression network between up- and down-regulated DElncRNAs and DEmRNAs in the Nrf2 (--/--) hippocampus. **(A)** Subnetwork of ENSMUST00000125413. **(B)** Subnetwork of NR_028123. **(C)** Subnetwork of uc008nfy.1. **(D)** Subnetwork of AK076764. **(E)** Subnetwork of AK142725. **(F)** Subnetwork of AK035903. **(G)** Subnetwork of AK080547. The triangles, squares represent up- and down-regulated DElncRNAs, and ellipses represent DEmRNAs in the Nrf2 (--/--) hippocampus. Red and blue color represent up- and down-regulation in the Nrf2 (--/--) hippocampus, respectively.](fnmol-12-00196-g007){#F7}

Discussion
==========

In recent years, Nrf2, as a cytoprotective transcription factor with antioxidant effects, has aroused broad interest. Many microarray analyses based on the expression profiling of liver, intestine, and lung tissues of Nrf2 (−/−) mice have been performed ([@B8]; [@B49]; [@B38]). Activation of the Nrf2-ARE pathway has been shown to confer benefits on many neurodegenerative disorders in animal models, which supports the concept of developing pharmaceuticals to activate the Nrf2-ARE pathway in the brain. As an indicator and regulator of oxidative stress, the Nrf2-ARE pathway has been shown to undergo dynamic changes and has been examined for its neuroprotective role in many cases ([@B19]). Nevertheless, further studies on Nrf2 need to be performed. To reveal the important role of circRNAs and lncRNAs associated with Nrf2-mediated neuroprotection in the brain, DEcircRNAs and DElncRNAs in the hippocampal tissues between Nrf2 (−/−) and Nrf2 (+/+) mice were identified by microarray and bioinformatics analysis.

The hippocampus is implicated in episodic memory and plays a pivotal role in particular aspects of the acquisition of semantic or factual knowledge ([@B7]). Long-term memory consists of episodic memory and semantic memory, which is closely associated with LTD and long-term potentiation (LTP). In general, memories are reorganized into widely distributed cortical networks over time through systems-level consolidation. At the cellular level, it is believed that storage of information initially occurs *via* altered synaptic strength through processes such as LTP ([@B40]). Synaptic plasticity is believed to be a putative biological substrate for learning and memory processes, and a mammalian target of rapamycin (mTOR) contributes to regulating synaptic remodeling and long-term synaptic plasticity in the hippocampus ([@B47]; [@B26]; [@B34]). LTD and LTP, as two main forms of synaptic plasticity in the brain, have been demonstrated to account for the onset and progression of motor symptoms of PD ([@B33]). Plastic changes in synaptic efficacy, such as LTD and LTP, are widely recognized as mechanisms implicated in learning and memory, responses to drugs of abuse, and addiction ([@B24]). In the CA1 region, a hippocampal subregion, the induction of homosynaptic LTD requires the activation of *N*-methyl-[D]{.smallcaps}-aspartate (NMDA) receptors ([@B6]), voltage-gated calcium channels ([@B4], [@B5]) and/or calcium release from intracellular stores ([@B30]).

In our analysis, four DEmRNAs (SLC6A3, DRD2, LPHN3, and DLG4) were enriched in response to cocaine, which was associated with addiction. Five DEmRNAs (STAG3, TEX15, CCNB1IP1, MAEL, and TEX11) were enriched in synapses. Five DEmRNAs (TRHR, P2RX1, CAMK4, CACNA1G, and RYR1) were enriched in the calcium signaling pathway. As mentioned above, three DEmRNAs (IGF1, RYR1, and PLA2G12A) were enriched in LTD. Among them, SLC6A3, TRHR, TEX15, MAEL, CACNA1G, and PLA2G12A were targets of mmu_circRNA_33836; SLC6A3, LPHN3, TEX15, MAEL, TRHR, RYR1, and IGF1 were targets of mmu_circRNA_008691; DLG4, STAG3, CCNB1IP1, TEX11, and P2RX1 were targets of mmu_circRNA_45901; and CAMK4, CACNA1G, and RYR1 were targets of mmu_circRNA_34137. Altogether, we speculate that mmu_circRNA_33836, mmu_circRNA_008691, mmu_circRNA_45901 andmmu_circRNA_34137 may play a central role in learning and memory. Importantly, in our previous study, mmu_circRNA_33836 and mmu_circRNA_34137 were down-regulated in the substantia nigra and corpus striatum between Nrf2 (−/−) and Nrf2 (+/+) mice, and this consistent result emphasized the critical function of mmu_circRNA_33836 and mmu_circRNA_34137 in Nrf2-mediated neuroprotection ([@B55]).

Parkinson's disease, as the second most prevalent neurodegenerative disorder after AD in the world, is characterized by cardinal motor symptoms, such as bradykinesias, rigidity, postural instability, resting tremor, and non-motor symptoms including psychiatric problems, autonomic disturbances, pain, fatigue, and impaired cognition in executive functioning, memory and spatial behavior during the early stage of the disease ([@B51]; [@B3]). The loss of dopaminergic neurons in the substantia nigra with Lewy bodies (intracytoplasmic inclusion deposits of aggregated alpha-synuclein and ubiquitin protein, and damaged nerve cells) is the primary pathology of PD ([@B13]; [@B52]). Much effort has been made to explore the mechanisms underlying the pathogenesis of PD. Studies of mitophagy in PD support the role of dysfunctional autophagy as a causative factor in neurodegenerative diseases ([@B28]). A growing number of studies highlight that disturbance in mTOR signaling in the brain affects multiple pathways including glucose metabolism, energy production, mitochondrial function, cell growth and autophagy, which are key players in age-related cognitive decline ([@B32]). However, a critical question of whether mTOR is neuroprotective or potentially promotes PD pathogenesis has been raised ([@B2]; [@B18]). In the present study, we also detected that five DEmRNAs, including COX7B2, UBA1Y, VAT1, CYCT and SLC6A3, were enriched in the pathway of Parkinson's disease. Among them, CYCT and SLC6A3 were co-expressed with the lncRNA ENSMUST00000125413; COX7B2, UBA1Y, and VAT1 were co-expressed with the lncRNAs AK142725 and AK035903, suggesting that these three DElncRNAs (ENSMUST00000125413, AK142725 and AK035903) may play a vital role in neurodegenerative diseases such as PD.

The activity-regulated cytoskeletal-associated protein (Arc) is an immediate early gene that has been broadly involved in hippocampal-dependent learning and memory, and is believed to play an integral role in synapse-specific plasticity ([@B36]). Arc mRNA is targeted to activated regions of the dendrite after LTP of the DG, a process dependent on NMDA receptor activation ([@B29]). According to [@B35] despite intact short-term memory, Arc knockout mice failed to form long-lasting memories for implicit and explicit learning tasks and exhibited a biphasic alteration of hippocampal LTP in the DG and area CA1 with an enhanced early and absent late phase. Furthermore, LTD is significantly impaired. They suggested that Arc play a vital role in the consolidation of enduring synaptic plasticity and memory storage ([@B35]). In the present study, Arc, a significantly up-regulated DEmRNA in the hippocampal tissues of Nrf2 (−/−) mice, was co-expressed with ENSMUST00000125413 and uc008nfy.1, which suggested that these two DElncRNAs were associated with learning and memory.

The cytochrome C oxidase VIIb2 (COX7B2) gene is a member of the cytochrome C oxidase (COX) superfamily ([@B46]). The COX complex, consisting of the COX7B2 subunit with other subunit polypeptides and localized to mitochondria, participates in the electronic transportation process of oxidative phosphorylation (OXPHOS) and in the maintenance of the electrochemical gradient in the mitochondrial membrane ([@B20]). Oxidative damage is closely associated with the pathogenesis of neurodegenerative diseases including AD, ALS, HD, PD, and stroke (brain ischemia/reperfusion injury) ([@B15]). In post mortem brains of advanced PD patients, dysfunction of mitochondrial OXPHOS protein complexes with decreased activity of complex I was detected, which indicates that mitochondrial dysfunction, especially OXPHOS, is strongly implicated in PD ([@B41]; [@B12]; [@B42]; [@B16]). In our results, COX7B2 was co-expressed with AK142725 and AK035903, which suggests that AK142725 and AK035903 may be involved in OXPHOS.

Conclusion
==========

Compared to Nrf2 (+/+) mice, we identified 1279 DEcircRNAs and 303 DElncRNAs in the hippocampus of Nrf2 (−/−) mice. Among them, mmu_circRNA_33836, mmu_circRNA_008691, mmu_circRNA_45901, and mmu_circRNA_34137 may play a critical role in learning and memory. ENSMUST00000125413, uc008nfy.1, AK142725 and AK035903 may be involved in neurodegenerative diseases by mediating the process of learning and memory and OXPHOS. Our study might represent a new avenue for future investigations to better understand the molecular mechanisms of Nrf2-mediated neuroprotection.
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